Image Trademark with Serial Number 79069161
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Image for trademark with serial number 79069161
Serial Number
79069161
Registration Number
3771814
Word Mark
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2018-02-15
Filing Date
2008-02-14
Registration Number
3771814
Registration Date
2010-04-06
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
020133, 021109, 040703, 260102, 260303, 260317, 260321, 280103 - Grotesque men formed by letters, numbers, punctuation or geometric shapes. Bodies or dummies without heads or without feet. Geometric figures or combinations of geometric figures representing a person. Plain single line circles. Incomplete ovals. Concentric ovals and ovals within ovals. Ovals that are completely or partially shaded. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2010-01-19
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
MARTIN, JENNIFER MCGAR
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of an oval inside of which appears a stick figure shape formed from a circle above a rectangle with rounded edges and which dissects an oval shape. The transliteration of the non-Latin characters, which appear below the design, is "YI LING", which are the Chinese characters constituting the first name of the president of the applicant. The two characters as so combined do not have any meaning in English.
Goods and Services
Pharmaceutical preparations for the treatment of cardiovascular system diseases, namely, hypertension, and heart failure; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of nutrition metabolism barrier diseases, namely, malnutrition and beriberi; Pharmaceutical preparations for the treatment of metabolism diseases, namely, diabetes, obesity, diabetic ketoacidosis, hypoxemia DKA and high fat proteinemia; Pharmaceutical preparations for the treatment of endocrine system diseases, namely, next cerebral ganglion pituitary gland sickness, thyroid gland sickness, ophoropathy and parathyroid sickness; Pharmaceutical preparations for the treatment of circulatory system diseases, namely, shock, heart valve sickness, arrhythmia, arteriosclerosis, cardiomyopathy periphery blood vessel disease, hypertensive disease and pericarditis; Pharmaceutical preparations for the treatment of respiratory disorder, namely, chronic bronchitis, bronchial asthma, disease of pulmonary circulation, pneumonia and acute trachea bronchitis; Pharmaceutical preparations for the treatment of digesting system diseases, namely, abdominal pain, constipation, diarrhea, cholecystitus, liver cirrhosis, liver function failure and gastritis; Pharmaceutical preparations for the treatment of urinary system diseases, namely, kidney stone, renal tumor, chronic kidney function failure, urinary tract infection and cystonephrosis; Pharmaceutical preparations for the treatment of hematopoietic system diseases, namely, anemia, leukemia and lymphoma; Pharmaceutical preparations for the treatment of immune system diseases, namely, serum sickness, allergic shock and allergic rhinitis; Pharmaceutical preparations for the treatment of rheumatic diseases and osteoarthritis, namely, rheumatic fever, lupus erythematosus, sjogren's syndrome, behcet disease and dermatomyositis; Pharmaceutical preparations for the treatment of nerve diseases, namely, schizophrenia and neurosis; Pharmaceutical preparations for the treatment of nervous system diseases, namely, headache, multiple sclerosis and muscle diseases; Pharmaceutical preparations for the treatment of skin diseases, namely, eczema, belt-shaped blister measles, namely, herpes zoster, connective tissue disease, lupus erythematosus and nervous dermatitis; Pharmaceutical preparations for the treatment of reproductive system inflammation, namely, pelvic inflammatory disease, cervicitis and vestibule big gland inflammation; Pharmaceutical preparations for the treatment of natural dissemination diseases, namely, gonorrhea, syphilis and AIDS; Pharmaceutical preparations for the treatment of female reproductive system tumor, namely, sarcoma uteri, carcinoma of cervix and endometrium cancer; Pharmaceutical preparations for the treatment of menopathy, namely, menopause, painful menstruation and menopause syndrome; Pharmaceutical preparations for the treatment of newborn symptom and diseases, namely, the newborn faints from fright, newborn vomit and newborn septicaemia; Pharmaceutical preparations for the treatment of surgical department conditions, namely, tetanus, wounds and tumors
Transliteration Statement
The non-Latin characters in the mark transliterate to "YI LING" and this has no meaning in a foreign language.
Translation of Words in Mark
The wording "YI LING" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2016-11-11
Primary Code
005
Correspondences
Name
WILLIAM J. SEITER
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1003607
International Registration Date
2008-02-14
International Publication Date
2009-07-02
International Renewal Date
2018-02-14
Auto Protection Date
2011-05-19
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2018-02-15
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2009-06-25SN ASSIGNED FOR SECT 66A APPL FROM IB
2009-06-26NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2009-06-26ASSIGNED TO EXAMINER
2009-06-29NON-FINAL ACTION WRITTEN
2009-06-30APPLICATION FILING RECEIPT MAILED
2009-06-30NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2009-06-30REFUSAL PROCESSED BY MPU
2009-06-30NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2009-07-24REFUSAL PROCESSED BY IB
2009-11-05TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2009-11-05ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2009-11-05TEAS RESPONSE TO OFFICE ACTION RECEIVED
2009-11-18ASSIGNED TO LIE
2009-11-18CORRESPONDENCE RECEIVED IN LAW OFFICE
2009-11-18TEAS/EMAIL CORRESPONDENCE ENTERED
2009-11-20CORRECTION TRANSACTION RECEIVED FROM IB
2009-12-08EXAMINERS AMENDMENT -WRITTEN
2009-12-08EXAMINERS AMENDMENT E-MAILED
2009-12-08NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2009-12-08EXAMINER'S AMENDMENT ENTERED
2009-12-08APPROVED FOR PUB - PRINCIPAL REGISTER
2009-12-14LAW OFFICE PUBLICATION REVIEW COMPLETED
2010-01-19PUBLISHED FOR OPPOSITION
2010-01-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2010-04-06REGISTERED-PRINCIPAL REGISTER
2010-07-07FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2010-07-28FINAL DISPOSITION PROCESSED
2010-07-28FINAL DISPOSITION NOTICE SENT TO IB
2013-02-07FINAL DECISION TRANSACTION PROCESSED BY IB
2016-03-25TEAS CHANGE OF CORRESPONDENCE RECEIVED
2016-11-11CANCELLED SECTION 71
2017-07-11TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
2017-07-13GENERIC MADRID TRANSACTION CREATED
2017-07-13GENERIC MADRID TRANSACTION SENT TO IB
2017-08-04TOTAL INVALIDATION PROCESSED BY THE IB
2018-01-11CHANGE OF NAME/ADDRESS REC'D FROM IB
2018-08-31DEATH OF INTERNATIONAL REGISTRATION
2018-08-31NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED